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SUMMARY 
 
Uveitis (intraocular inflammation) is a leading cause of vision loss.  Although its etiology is 
largely speculative, it is thought to arise from complex genetic-environmental interactions that 
break immune tolerance to generate eye-specific autoreactive T cells.  Experimental autoimmune 
uveitis (EAU), induced by immunization with the ocular antigen, interphotoceptor retinoid 
binding protein (IRBP), in combination with mycobacteria-containing CFA, has many clinical 
and histopathological features of human posterior uveitis.  Studies in EAU have focused on 
defining pathogenic CD4
+
 T cell effector responses, such as those of Th17 cells, but the innate 
receptor pathways precipitating development of autoreactive, eye-specific T cells remain poorly 
defined.  In this study, we found that fungal-derived antigens possess autoimmune uveitis-
promoting function akin to CFA in conventional EAU.  The capacity of commensal fungi such as 
C. albicans or S. cerevisae to promote IRBP-triggered EAU was mediated by Card9.  Since 
Card9 is an essential signaling molecule of a subgroup of C-type lectin receptors (CLRs) 
important in host defense, we further evaluated the proximal Card9-activating CLRs.  Using 
single receptor-deficient mice, we identified Dectin-2, but not Mincle or Dectin-1, as a 
predominant mediator of fungal-promoted uveitis.  Conversely, Dectin-2 activation by α-mannan 
sufficiently reproduced the uveitic phenotype of EAU, in a process mediated by the Card9-
coupled signaling axis and IL-17 production.  Taken together, this report relates the potential of 
the Dectin-2/Card9-coupled pathway in ocular autoimmunity.  Not only does it contribute to 
understanding of how innate immune receptors orchestrate T cell-mediated autoimmunity, it also 
reveals a previously unappreciated ability of fungal-derived signals to promote autoimmunity.  
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INTRODUCTION 
 
Uveitis (intraocular inflammation), a leading cause of vision loss in the Western world [1, 2], 
exists as an isolated condition or can occur as a manifestation of some systemic autoimmune 
diseases.  Approximately 10% of cases of severe vision loss are thought to be attributed to 
autoimmune uveitis [3].  While the importance of autoreactive T cells is well-accepted in 
autoimmune uveitis, it is also known that innate signals, e.g. initiated by microbial detection, are 
required to generate pathogenic cellular responses.  In classical experimental autoimmune uveitis 
(EAU), mice immunized with the retinal antigen, interphotoreceptor retinoid binding protein 
(IRBP), in the presence of CFA containing M. tuberculosis, develop T cell-mediated intraocular 
inflammation that clinically and pathologically resembles human uveitis [4].  Th1 and Th17 
responses are known immunopathological mechanisms in EAU [4], yet little is known about the 
innate receptors that initiate this disease.   To date, research on innate receptors in the eye has 
focused primarily on the contribution of Toll-like receptors (TLRs) to a wide range of ocular 
diseases.  In ocular autoimmunity, as modeled in EAU, TLRs have been reported to play 
redundant roles, as mice deficient for TLRs 2, 3, 4 or 9 (as well as double-knockout (KO) mice) 
develop EAU comparable to their WT counterparts [5, 6].  Studies should therefore be broadened 
to include consideration of other innate receptor families, such as C-type lectin receptors (CLRs) 
or NOD-like receptors (NLRs), which have emerged as essential factors in host defense against 
microbes, but whose dysregulation has also been linked with inflammatory disease [7].  In the 
proposed paradigm where autoimmune disease develops as a result of complex interactions 
between individual genes and the environment (e.g. microbes, toxins, etc.), further exploration of 
innate receptor function in autoimmune uveitis is warranted.   
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The CLR family of immune sensors constitute an integral part of host defense against fungal 
infection via their ability to recognize components of the carbohydrate-rich cell walls of fungi 
such as Candida spp. or mycobacteria [8-10].  Several well-studied CLRs including Dectin-1, 
Dectin-2 and Mincle are known to elicit inflammatory responses through the adaptor molecule 
caspase-associated recruitment domain adaptor 9 (Card9) [11].  Intriguingly, Mincle and its 
associated Card9-coupled signaling axis were recently identified as a key pathway in the 
development of EAU [12].  Dectin-1 has also been implicated in EAU [13], thereby supporting 
an autoimmunity-promoting function for CLR family members in events that underlie break in 
tolerance and development of uveitis.   
 
Aside from Dectin-1, which directly activates the protein tyrosine kinase Syk, other CLRs (e.g. 
Mincle, Dectin-2, Dectin-3) associate with FcRγ in order to activate Syk and subsequent signal 
transduction mediated by the adaptor molecule Card9.  Assembly of a multi-protein complex 
involving Card9, Bcl10 and Malt1 is required for activation of MAPK- and NF-κB-mediated 
transcription of a network of genes important for  generation of Th1 and Th17 responses [14].  
While the Card9-activating CLRs may have differential roles in infection, Card9 expression 
appears absolutely critical for host defense against fungal and mycobacterial infection [15, 16].  
Indeed, patients with mutations in CARD9 succumb to candidemia [17, 18], an observation 
which has been investigated at a functional level in Card9-deficient mice infected with C. 
albicans [16].  On the other hand, dysregulation of CARD9 also appears to be related to immune 
dysfunction, as it has been identified as a major genetic susceptibility determinant in systemic 
autoimmune diseases [19, 20].  It is thus intriguing to consider a central Card9-pathway that 
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exists at a pivotal intersection between microbial sensing and autoimmune disease.  These 
collective observations led us to postulate that fungi could provide sufficient innate cues to elicit 
autoimmune uveitis via Card9 activation.   
 
C. albicans is a commensal organism found in harmless association with humans, but can be 
pathogenic in immunocompromised individuals.  Yet, here we report that innate cues provided 
solely by C. albicans or another commensal fungus (S. cerevisiae) are capable of promoting 
IRBP-triggered autoimmune uveitis in immunocompetent mice akin to classical EAU through a 
Card9-dependent mechanism.  Conceptually, this observation is intriguing because it uncovers a 
previously unconsidered capacity for commensal fungi to promote autoimmunity akin to that of 
mycobacteria-containing CFA, a commonly used adjuvant for induction of EAU as well as other 
experimental autoimmune disease models.  Moreover, the fungal-promoted form of uveitis is 
initiated by activation of Dectin-2, rather than Mincle or Dectin-1, and α-mannan sufficiently 
replicates the uveitis phenotype induced by C. albicans via a Dectin-2/Card9-coupled 
mechanism.  This report extends our understanding of innate receptors in ocular autoimmunity 
beyond TLRs to include CLRs, thereby revealing the potential for fungal-derived components as 
environmental triggers of autoimmune uveitis.  Our data, along with those of others, point to the 
Card9 pathway as an important mechanism in the control of immune tolerance and 
autoimmunity, a concept that could influence how we approach the study of autoimmune 
diseases. 
 
MATERIALS AND METHODS 
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Mice:  B10.RIII and C57BL/6J mice were purchased from The Jackson Laboratory (Bar Harbor, 
ME).  C57BL/6 mice lacking expression of Card9, Mincle, Dectin-2, and Dectin-1 (encoded by 
Card9, Clec4e, Clec4n, Clec7a, respectively) have been described [8-10, 12, 21, 22].  Littermate 
controls were used to generate wild type (WT) and homozygous null mice, and all animals were 
bred in-house under specific pathogen-free (SPF) conditions at the VA Portland Health Care 
System.  Mice aged between 8-12 weeks were used in experiments.  All studies were carried out 
in accordance with the U.S. Department of Health and Human Services Guide for the Care and 
Use of Laboratory Animals, and were performed under institutional protocols approved at the 
VA Portland Health Care System.   
 
Induction of autoimmune uveitis:  Induction of ocular autoimmunity was modeled after the 
classical model of EAU which employs CFA [12, 23].  Here, mice were immunized 
subcutaneously (s.c.) with 200 µl of an emulsion (1:1 v/v) of IRBP (125 µg purified IRBP + 300 
µg IRBP1–20 peptide (Anaspec, Fremont, CA)) and IFA containing 2.5 mg/ml (or ~1.5 x10
7
 
cells/mouse) of the fungal agonists: heat-killed C. albicans (HKCA; ATCC 10231, Invivogen), 
heat-killed S. cerevisiae (HKSC; ATCC 32119, Invivogen), α-mannan from C. albicans as 
described [24, 25] or purchased (Sigma).  In the case of the highly susceptible B10.RIII strain, 
mice were immunized with 25 µg IRBP161-180 peptide emulsified in fungal-supplemented IFA 
without pertussis toxin.  For comparison, some studies included induction of EAU as per 
standard methods using CFA (Sigma) and 2.5 mg/ml M. tuberculosis (H37RA, Difco) [12]; or 
with IFA reconstituted with the mycobacterial cell-wall derived products: trehalose-6,6'-
dibehenate (TDB, a synthetic analogue of mycobacterial cord factor; InvivoGen), peptidoglycan 
(PGN; InvivoGen) and muramyl dipeptide (MDP; Bachem, Torrance, CA).   
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Evaluation of clinical and histopathology of uveitis:  Clinical fundus (posterior eye) images 
were acquired from live, anesthetized mice by topical endoscopic fundus imaging (TEFI) and the 
severity of inflammation was graded on a scale of 0 to 4 [12] as detailed [12].  At the termination 
of studies, eyes were harvested, and ocular histopathological changes were scored for severity on 
a scale of 0 to 4 [12].  The numbers of leukocytes infiltrating the anterior chamber and vitreous 
cavity were counted from histological sections.  All scoring and enumeration were conducted in 
masked fashion. Representative images acquired (at 200X original magnification). 
 
Multiplex quantitative real-time PCR:  Dissected retinas from both eyes were pooled (n=6 
mice/condition).  Total RNA was extracted (RNeasy kit, Qiagen), and cDNA was synthesized 
(Reverse Transcription Kit, Applied Biosystems).  Transcripts were analyzed using multiplex 
quantitative real-time PCR (RT
2
Profiler
TM
 PCR Gene Expression Assay kit, SABiosciences) and 
the PRISM® Sequence Detection system (Applied Biosystems) as described [12].  Array results 
are representative of four independently performed experiments, with a total of 24 
mice/condition.   
 
Antigen-recall assay of Th17 response-related cytokine production:   To evaluate the antigen-
specific Th17 cellular response, single cell suspensions prepared from spleens harvested 14d 
post-immunization were stimulated as previously reported [12].  Briefly, splenocytes were 
seeded in round-bottomed, 96-well tissue culture plates (1.5x10
6
 cells/200 µl) and cultured 
overnight in the presence or absence of 20 µg/ml IRBP1–20 peptide (Anaspec).  Supernatants 
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were then collected and the concentration of IL-17A was measured as per manufacturer’s 
instructions (Mouse IL-17 DuoSet ELISA; R&D Systems). 
 
Immunoblotting:  Ocular tissues were dissected and pooled (n=3 mice/tissue), and homogenized 
in lysis buffer.  Immunoblotting was performed using antibodies to: Mincle (clone 4A9, MBL 
International), Dectin-1 (clone 2A11, AbD Serotec), Dectin-2 (polyclonal, Abcam), and β-actin 
(clone AC-15, Sigma), which were then detected with IRDye®-conjugated secondary antibodies 
and visualized with an Odyssey® scanner and software (LI-COR Biosciences).  Results are 
representative of three independently performed experiments. 
 
Statistical analysis:  For quantitative real-time-PCR, conditions were compared using ANOVA 
with Tukey-Kramer post-hoc (Prism, GraphPad Software).  For non-parametric data (i.e., clinical 
and histopathology scores), the Mann–Whitney U test (two-tailed) was used for comparison 
testing.  All experiments were independently repeated.  Results are presented as mean ± SEM 
and p<0.05 was considered significant. 
 
RESULTS  
 
C. albicans-derived signals promote autoimmune uveitis. 
 
In light of the recently identified importance for the Card9-signaling pathway in induction of 
classical EAU [12], we hypothesized that fungi recognized by CLRs could similarly elicit 
autoimmune uveitis via a Card9-mediated mechanism.  To explore this postulate, we first tested 
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whether substitution of mycobacteria with fungi could elicit ocular autoimmunity.  Mice were 
immunized with IRBP in IFA (devoid of mycobacteria) that was supplemented with C. albicans 
instead.  Clinical monitoring by fundus imaging revealed uveitis onset 7-14 days following 
immunization that continued to worsen up to 21d (Fig. 1A). This IRBP-dependent uveitis, which 
first appeared at and around the optic nerve head (arrow head; Fig. 1B), progressed along the 
blood vessels (i.e. retinal vasculitis), and encompassed larger areas of retinal lesions over time 
(Fig. 1B).  Histopathology corroborated the clinical findings (Fig. 1C,D), and revealed 
pronounced pathological features including retinal structural damage (i.e. folding), vasculitis 
(green asterisk, Fig. 1D) and perivascular exudates in the ganglion cell layer (GCL).  
Granulomatous-like inflammation in the neural retina was consistently observed within the inner 
and outer nuclear layers (INL and ONL) as well as the retinal pigmented epithelial (RPE) layer.  
Extensive chorioretinal infiltrates were also frequently observed with subretinal hemorrhage.  
Leukocyte infiltration into the intraocular cavities, an additional parameter of uveitis, was 
significantly increased in the vitreous of the posterior segment (PS) and aqueous humor of the 
anterior segment (AS) (Fig. 1E).  Importantly, control animals immunized with adjuvant alone 
(C. albicans-containing emulsion without IRBP) did not show any clinical or histopathological 
evidence of uveitis (Fig. 1); thereby underscoring the combinatorial requirement for innate 
signals provided by fungi and autoantigen in eliciting uveitis.   
 
Fungal-promoted uveitis requires Card9 but is independent of Mincle.   
 
Sensing of cord factor (or trehalose-6,6-dimycolate, TDM), a constituent of M. tuberculosis cell 
wall and immunostimulatory component of CFA [26], by the CLR Mincle is an important factor 
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in host defense against M. tuberculosis infection [27].  Mincle is also reported to be involved in 
detection of C. albicans [10], although the identity of the C. albicans ligand(s) remain(s) 
unknown.  Since Mincle was previously identified as a CLR responsible in activation of a Card9-
mediated mechanism in classical EAU [12] and the C. albicans-promoted uveitis observed here 
has pathological features and kinetics similar to classical EAU, we theorized that a similar 
mechanism, involving Mincle/Card9-coupled signaling, would be functionally important in 
fungal-promoted uveitis.  Contrary to our postulate, Mincle-deficiency had a negligible effect on 
fungal-promoted uveitis, as evaluated both clinically and histopathologically (Fig. 2A, C).  The 
protective effect of Mincle-deficiency as reported [12], however, was reproduced with IRBP-
immunization using CFA (Supplemental Figure 1A).   
 
Nonetheless, we found Card9 to be a requirement for induction of fungal-promoted uveitis, as 
disease severity was dramatically reduced in the absence of Card9 expression (Fig. 2B, C).  Most 
clinical and histological disease features were attenuated in Card9-deficient mice relative to WT; 
albeit we noted some mild inflammation surrounding optic nerve and blood vessels remained 
(Fig. 2C).  These results suggest either a redundancy amongst CLRs and/or involvement of 
additional CLR(s) apart from Mincle in C. albicans-promoted uveitis.  Intriguingly, the 
development of fungal-derived uveitis was not limited to C. albicans, because similar results 
were obtained in studies using another commonly encountered fungus, S. cerevisiae 
(Supplemental Fig. 1B, C).  Card9-deficiency also ameliorated S. cerevisiae-induced uveitis, 
demonstrating the central role for Card9 in promotion of ocular autoimmunity in the context of 
fungi. 
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The Dectin-2/Card9 coupled signaling axis promotes autoimmune uveitis. 
 
The above data underscore the central importance of the Card9 pathway in induction of ocular 
autoimmunity, be it promoted by fungi or mycobacterial triggers.  They also suggest that signal 
activation may originate from unique CLRs apart from Mincle.  The Card9-coupled CLRs 
Dectin-1 and Dectin-2 recognize β-1-3-glucan-containing and high mannose-based 
polysaccharides, respectively, both of which comprise a large portion of the cell wall of C. 
albicans and many other fungi [9, 28].  We have observed unique baseline protein expression 
profiles amongst the CLRs in naïve murine ocular tissues (Fig. 3A), with Dectin-2 expressed at 
considerable higher levels than Dectin-1 or Mincle within the retina (the primary tissue target in 
IRBP-induced uveitis).  To address whether either of Dectin-1 or Dectin-2 might be involved in 
triggering fungal-uveitis, we evaluated uveitis severity in single receptor KO mice.   Our data 
indicate that C. albicans-promoted uveitis occurs independent of Dectin-1 expression, as 
evaluated both clinically and histopathologically (Fig. 3B, C), suggesting either a redundant or 
non-essential role for Dectin-1 in C. albicans-promoted uveitis.  However, uveitis was 
significantly reduced in Dectin-2 KO mice based on both clinical and histopathological 
assessment (Fig. 3D, E), indicating a novel role for Dectin-2 in the promotion of uveitis.  In 
contrast to fungal-derived uveitis in WT mice, Dectin-2 KO mice exhibited marked reduction in 
retinal folding, photoreceptor destruction and granulomatous inflammation within the ONL and 
RPE layers.  Clinical fundus imaging of these Dectin-2-deficient mice revealed residual 
inflammation seen primarily along the retinal vasculature (indicated by green asterisk in fundus 
image; Fig. 3E), which is a consistent pathological feature observed in fungal-derived uveitis in 
WT mice (green star, H&E-stained histology image; Fig. 3E).  This indicates a residual Dectin-2 
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independent mechanism in the pathogenesis of fungal-derived uveitis.  Adjuvant-injected control 
mice of either genotype showed no detectable histopathological or clinical signs of uveitis (n=6 
mice/genotype; data not shown).  
 
Collectively, the above data indicate that despite a shared ability amongst these CLRs to 
recognize fungal cell components and signal by way of Card9, Dectin-2, but not Dectin-1 or 
Mincle, plays a hitherto unrecognized role in C. albicans-dependent uveitis.  To further 
investigate the ability of Dectin-2 in promotion of ocular autoimmunity, we explored whether 
uveitis could be reproduced using the recently identified Dectin-2 agonist, α-mannan [9].  
Initially, the ability of α-mannan to elicit IRBP-induced uveitis was screened in B10.RIII mice, a 
strain that is known to be highly susceptible to EAU.  Mice immunized with IRBP in conjunction 
with purified α-mannan (in lieu of intact C. albicans) developed robust uveitis (Fig. 4A), which 
was comparable to that promoted by C. albicans.  Interestingly, we noted that the capacity of α-
mannan to elicit ocular autoimmunity was similar to that of CFA (used in classical EAU), and 
was significantly more potent than mycobacterial agonists TDB, peptidoglycan (PGN) or 
muramyl dipeptide (MDP), all of which have been previously regarded as the responsible 
immunostimulants of CFA adjuvant.  Negative control mice immunized with α-mannan in IFA 
alone (in the absence of IRBP) did not develop clinical or histopathological signs of uveitis, 
thereby demonstrating requirement for antigen.   
 
The interaction between α-mannan and Dectin-2 in induction of uveitis was further evaluated 
using Dectin-2 KO mice (Fig. 4B, C).  In contrast to uveitis promoted by α-mannan in WT mice, 
uveitis was significantly attenuated in Dectin-2 KO mice, as determined by clinical and 
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histopathological scoring (Fig. 4B, C), thereby signifying the importance of α-mannan in 
activating Dectin-2 in C. albicans-promoted uveitis.  Finally, we determined whether the uveitis 
promoted by α-mannan/Dectin-2 interaction also required Card9.  Indeed, Card9 deficiency 
significantly ameliorated uveitis, by both clinical and histopathological measures (Fig. 4B, C).  
Interestingly, the residual vessel damage and vasculitis was again noted in Dectin-2 KO mice 
(depicted in fundus and histology images; Fig. 4C, green asterisks), indicating a potential for α-
mannan to elicit vasculitis via a Dectin-2-independent mechanism.  Collectively, these data 
support the ability of α-mannan to promote development of autoimmune uveitis, which involves 
a Dectin-2/Card9-coupled mechanism.  
 
The Th17 response is a key aspect of host defense against fungal infection in which the Card9-
pathway mediates transcription of cytokines and chemokines that promote Th17 differentiation 
[14].  The flip side is that the Th17 response has also been established as a pathogenic 
mechanism that drives autoimmune uveitis [4].  To gain further insight into the extent to which 
polarizing factors associated  with the Th17 response might be induced in fungal-promoted 
uveitis,  we examined the transcriptional response in the retina, focusing particularly on a group 
of previously identified Card9-controlled signatures [12].  Examination of retinas dissected from 
mice with fungal-promoted uveitis revealed substantial induction of a number of cytokines and 
chemokines related to promotion of Th17 responses (Fig. 4D), as well as factors related to 
microbial detection such as: complement components C3 and C5aR, TLRs, and the Nod-like 
receptor (NLR) family member Nlrp3.  Notably, genes encoding CLRs such as Mincle (Clec4e), 
Dectin-1 (Clec7a), and Dectin-2 (Clec4n) were all highly upregulated in retinas of immunized 
mice.  Using antigen-recall assays, we next examined the extent to which activation of the 
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Dectin-2/Card9-coupled axis elicits an IRBP-specific Th17-associated response (Fig. 4E). 
Antigen-stimulated splenocytes showed significant increase in IL-17A production compared to 
media controls.  Moreover, consistent with the marked reduction in uveitis, Card9-deficiency 
resulted in significantly reduced IRBP-specific induction of IL-17.  This data supports a role for 
the Dectin-2/Card9-coupled pathway in promotion of a Th17 cellular response in uveitis. 
 
 
DISCUSSION   
 
The discovery of innate receptors such as TLRs has revolutionized our understanding of the 
mechanisms underlying microbial sensing and host defense.  However, how innate receptor 
systems might be involved in autoimmunity remains poorly understood.  Here, we present data 
that: 1) reveals a previously unappreciated capacity for fungi to promote development of 
autoimmune uveitis, 2) identifies the CLR Dectin-2 as a critical receptor, and 3) affirms Card9 as 
a central signaling pathway for promoting uveitis and Th17 responses.  Together, this report 
sheds light onto microbial-host interactions in autoimmunity and provides a novel conceptual 
paradigm within which we can approach future exploration that could lead to the development of 
alternative therapies for autoimmune disease of the eye or other organs. 
 
These data reveal a novel role for Dectin-2 in its ability to promote autoimmune uveitis.  We 
noted a marked upregulation in genes encoding Card9-activating CLRs (Dectin-1, Dectin-2 and 
Mincle) within the retina in fungal-promoted uveitis.  While the baseline protein expression of 
CLRs in retinas of naïve mice appeared to vary, Dectin-2 expression was constitutively 
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expressed (Fig. 3A).  The cellular source(s) of CLRs such as Dectin-2 which function in uveitis 
remain to be determined, but our observations support consideration of Dectin-2 in neural tissues 
such as the eye or brain.  Retinal expression of Dectin-2 could be attributable to resident 
immune-related cells (e.g. microglia, astrocytes), similar to what has been observed for Dectin-2 
expression in microglia in the brain [29].  It is also worthwhile to consider expression and 
function of Dectin-2 in non-myeloid cells, as has recently been reported for Mincle in the case of 
ischemic brain injury [30].  Since CLRs are known to be predominantly expressed on myeloid 
cells [14], ocular function of Dectin-2 during uveitis could be further mediated by peripheral 
dendritic cells during priming or by phagocytes such as neutrophils and macrophages that 
infiltrate the eye during uveitis.   
 
Few studies have examined the biological function of CLRs such as Dectin-2 in the context of 
autoimmunity.  In experimental autoimmune encephalomyelitis (EAE), a model for CNS 
autoimmunity that shares immunological mechanisms with EAU, it was recently reported that 
Dectin-2 promoted autoimmunity [31], which is in line with our present observation in uveitis.  
Collectively, their report and ours support Dectin-2 as a CLR important to human health and 
further studies are warranted in non-CNS related autoimmune models such as experimental 
arthritis, particularly given the association between polymorphisms in Clec4n (gene encoding 
Dectin-2) and rheumatoid arthritis  [32].  It is also interesting to consider how distinct microbial 
cues could elicit differential CLR activation. For example, our prior work in classical EAU 
(using CFA) demonstrated a role for Mincle, but not Dectin-2 [12].  This contrasts the present 
study on fungal-promoted uveitis, wherein Mincle was not involved.   In terms of other 
experimental models of autoimmunity, Dectin-1 has been identified as an important inducer of 
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arthritis in the genetically predisposed SKG strain of mice [33].  The differential roles of 
individual Card9-associated CLRs, be they activated by mycobacterial and/or fungal-derived 
signals, in distinct autoimmune-mechanisms will be an interesting avenue of future research. 
 
While the specific cellular and molecular mechanisms underlying the autoimmunity-promoting 
effects of the Dectin-2/Card9-pathway or of α-mannan were not explored in detail here, in vitro 
studies by others have demonstrated the requirement for Dectin-2 in cytokine responses (e.g. 
increased TNF, IL-6, IL-1β, IL-23 and IL-10) triggered by α-mannan [9].  In the case of Dectin-
2, the Card9 signaling pathway, which is initiated by FcRγ-coupled Syk and mediated by the 
multi-protein complex of Bcl10 and Malt1, leads to activation of MAPK- and NK-κB-mediated 
transcription, activation of the Nlrp3 inflammasome, and production of reactive oxygen species 
[14], all of which are thought to be important in optimization of the Th17-mediated anti-fungal 
immunity.  Our data support a central role for a Card9-mediated mechanism, as fungal-promoted 
uveitis as well as α-mannan-initiated uveitis were abrogated by Card9-deficiency.  Indeed, 
retinas of fungal-immunized mice showed induction of similar sets of cytokine and chemokine 
genes that are involved in promotion of Th17 responses, an important aspect of the Card9-
coupled signaling axis for controlling fungal infections [14].  Microbial detection genes such as 
complement components C3 and C5aR were also highly upregulated, which could be of 
functional relevance since anaphylatoxins C3a and C5a have been identified as mediators in 
classical EAU [34].  Also of note, the enhanced transcription of IL-1-related genes supports the 
requirement of the IL-1R/MyD88-signaling pathway reported in classical EAU [6], suggesting 
that the Nrlp3-inflammasome and downstream biological responses of IL-1 are a principal 
pathway for induction of ocular autoimmunity in both scenarios.  Thus, it seems conceivable that 
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CLR signaling, which has even been shown to regulate IL-17 in a feed forward autocrine fashion 
in both innate myeloid cells [35] and Th17 cells, could be an important mechanisms involved in 
the breakdown of immunological tolerance that leads to ocular autoimmunity through the Card9-
pathway. 
 
Another intriguing observation from this study was that α-mannan appeared inherently more 
potent than the individual mycobacterial components TDB, PGN, and MDP and equivalent to 
that of whole M. tuberculosis in CFA in inducing autoimmune uveitis (Fig 4A).  It would thus be 
intriguing and important to better understand the properties of α-mannan as it could have 
ramifications for adjuvant development.  As a recently identified Dectin-2 agonist, the biological 
responses to α-mannan exposure are still being defined, but the observation that injection of α-
mannan causes vasculitis in mice is especially interesting [36] given that α-mannan injection, 
even in Dectin-2 KO mice, have pronounced retinal vasculitis.  One interpretation of this would 
be that α-mannan-mediated effects on endothelial cells are involved in breakdown of the blood-
ocular barrier in uveitis.  The residual disease in α-mannan-immunized Dectin-2 KO mice would 
suggest involvement of an additional immune receptor(s) besides Dectin-2 that signals by way of 
Card9 in the sensing of C. albicans mannoproteins.  One putative candidate responsible for these 
attributes is the newly discovered CLR, Dectin-3, which is capable of forming a heterodimeric 
complex with Dectin-2 and acting synergistically to promote TNF, IL-6, and IL-17 production to 
C. albicans [37].  Alternatively, contaminants within the α-mannan preparation could 
conceivably activate CLRs-independent of Dectin-2 as well.  Further studies examining Dectin-3 
amongst in promotion of ocular autoimmunity would be of significant interest.   
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In conclusion, this study demonstrates that irrespective of upstream CLRs, the Card9 pathway is 
likely positioned at a crossroad between microbial response and autoimmune disease. Different 
classes of microbes that activate the Card9 pathway, including Mycobacteria or fungi, such as C. 
albicans or S. cerevisiae (as demonstrated here; supplementary data), have the capacity to 
provide the innate signals that drive retina-specific T cells in uveitis. Aberrant dysregulation of 
this pathway could be envisioned in genetically predisposed individuals, such as patients with 
CARD9 polymorphisms, who develop ankylosing spondylitis [19], a condition that is strongly 
linked to uveitis.  Given the ubiquity of C. albicans in our environment, demonstration of its 
relevance to disease may be complicated, but a number of observations in patients lend support 
to the concept of fungi as initiating and/or perpetuating factors in autoimmune disease.  Elevated 
levels of anti-S. cerevisiae antibodies (ASCA) have been documented in systemic inflammatory 
disorders including Crohn’s disease (another CARD9-linked condition) [20] and Behҫet’s disease 
[38, 39].  Notably, in Behҫet’s disease, uveitis is a diagnostic criterion [40], as up to 90% of 
patients with this condition develop uveitis [41].  The presence of anti-S. cerevisiae antibodies, 
and by extension T cells reactive to S. cerevisiae, in inflammatory disorders strongly linked with 
uveitis suggests that fungal elements may serve as important and previously unappreciated 
antigens capable of causing breaks in ocular-immune tolerance and predisposing individuals to  
uveitis. Certainly, observations made in autoimmune polyendocrinopathy, candidiasis, 
ectodermal dystrophy (APECED), argue for a more direct role for C. albicans in uveitis.  This 
rare autosomal recessive syndrome is caused by a mutation in AIRE [42] and characterized by 
organ-specific autoimmunity, including uveitis [43, 44], as well as chronic mucocutaneous 
candidiasis [42], suggesting an interaction between fungal-induced pathways and autoimmunity 
beyond candidiasis.   
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Remarkable advances have been made in the understanding of immune recognition processes by 
CLRs during C. albicans infection, but have been relatively limited in the areas of autoimmunity.  
However, because EAU shares essential immunological mechanisms with other tissue-specific 
autoimmune disorders, including experimental autoimmune encephalomyelitis, neuritis, arthritis, 
orchitis, and others, these findings expand our understanding of the importance of CLRs in 
autoimmune disease, whether they are activated by fungi or mycobacteria, and of the central 
importance of the Card9 pathway in driving retina-specific T cells.  Moreover, these findings 
could influence future basic science exploration of mechanisms of autoimmunity using 
experimental models that have historically relied on CFA. 
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Figure 1.  C. albicans-derived signals promote autoimmune uveitis.  Uveitis was evaluated in 
mice immunized with IRBP by both clinical examination (A,B) and histopathology scoring (C, 
D).  (B) Representative fundus images depicting uveitis; black arrow denotes the optic nerve 
head. (D) Representative histological images depicting pathological features; green asterisk 
indicates vasculitis.  L: lens; V: vitreous; R: retina.  Ganglion cell layer (GCL), inner nuclear 
layer (INL), outer nuclear layer (ONL), retinal pigment epithelium (RPE). (E) Enumeration of 
cells within the aqueous of anterior segment (AS) or vitreous cavity of posterior segment (PS).  
An asterisk (*) indicates significance in IRBP-immunized mice compared to adjuvant-
immunized (n = 10-20 mice/group/time from 2-3 experiments).  
 
Figure 2.  Fungal-derived uveitis requires Card9 but is independent of Mincle.  To assess 
the role of Mincle (A, C) or Card9 (B, C) in fungal-promoted uveitis, WT, Card9 KO and Mincle 
KO mice were immunized with IRBP in an emulsion containing C. albicans and uveitis was 
evaluated by clinical examination and histology on day 21.  (C) Clinical and histological images 
of the fundus and posterior eye are shown.  An asterisk (*) indicates significance compared to 
WT mice (n=12 mice/group combined from 2 independently p rformed experiments). 
 
Figure 3.  Dectin-2 contributes to pathogenesis of fungal-promoted uveitis. Representative 
immunoblotting of indicated ocular tissues (pooled from both eyes of n=3 mice) from naïve WT 
mice showing CLR expression (A).  Uveitis was induced in WT or Dectin-1 KO (B, C) vs. 
Dectin-2 KO (D, E) mice by immunization with IRBP in an emulsion containing C. albicans and 
evaluated by clinical and histological examination. Fundus and histological images of the 
posterior eye d21 post-immunization (green asterisk indicates vasculitis).  No significant 
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differences between WT and Dectin-1 KO mice were observed (n=10-12 mice/group combined 
from 2 independently performed experiments). An asterisk (*) indicates significance compared 
to WT mice (n=12 mice/group combined from 2 independently performed experiments). 
 
Figure 4.  Activation of the Dectin-2/Card9 coupled signaling axis promotes autoimmune 
uveitis.  B10.RIII mice were immunized with IRBP emulsified in IFA supplemented with α-
mannan and uveitis was scored from histological sections (A).  For comparison, mice were also 
immunized with heat-killed C. albicans (HKCA), CFA, or the mycobacterial-derived products 
TDB, PGN or MDP. An asterisk (*) indicates significance compared to CFA-immunized mice 
n=10 mice/group; combined from 2 independent experiments).  To determine the specific role(s) 
for Dectin-2 or Card9 in α-mannan-induced uveitis, disease severity was evaluated clinically and 
histopathologically in KO mice (B, C). An asterisk (*) indicates significance compared to WT 
mice while # indicates significance between Dectin-2 and Card9 KO mice (n=24 mice/group 
combined from 3 independently performed experiments).  (C) Fundus and histological images of 
the posterior eye d21 post-immunization. (D) Heat map showing retinal gene expression at d10 
post-immunization as evaluated by multiplex quantitative PCR analysis.  Fold-change in gene 
expression is relative to naïve control animals (n=6 mice pooled/group; array results are 
representative of 4 independently performed experiments).  (E) Cytokine concentration in culture 
supernatants was determined at 24 h post IRBP-stimulation by ELISA (n=5 mice/group, 
performed in triplicate). An asterisk (*) indicates significance compared to media-stimulated 
control cells. 
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Supplemental Figure 1.  EAU triggered by the yeast S. cerevisiae is mediated by Card9.  For 
comparison of the role of Mincle in the different modes of uveitis-induction, uveitis severity was 
evaluated in WT and Mincle KO mice immunized with standard CFA vs. C. albicans-containing 
adjuvant (A).   WT and Card9 KO mice were immunized with IRBP emulsified with heat-killed 
S. cerevisiae and uveitis was assessed clinically and histologically on d21 post-immunization (B, 
C).  (C) Examples of clinical and histological images of the posterior eye. An asterisk (*) 
indicates significance compared to WT mice (n=10-12 mice/group combined from 2 
independently performed experiments). 
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